.webp)
Causes of Non-Hodgkin's Lymphoma Treatment
Chemotherapy
Radiation Therapy
Targeted Therapy
Immunotherapy
Stem Cell Transplant (Bone Marrow Transplant)
Watchful Waiting (Active Surveillance)
Chemotherapy is the most common treatment for Non-Hodgkin’s Lymphoma (NHL). It uses powerful drugs to destroy cancer cells or stop them from growing. This treatment may be administered orally or intravenously and is often given in cycles.
Radiation therapy uses high-energy rays to target and kill cancer cells in specific parts of the body. It’s often used for localized lymphoma or in combination with chemotherapy to enhance effectiveness.
Targeted therapy focuses on specific molecules involved in cancer growth. For example, monoclonal antibodies like Rituximab bind to the CD20 protein on B-cells and help destroy them with minimal damage to healthy cells.
Immunotherapy helps boost the body’s natural defenses to fight the lymphoma. CAR T-cell therapy is a promising form of immunotherapy where a patient’s T-cells are modified to attack cancer cells more effectively.
This involves high-dose chemotherapy followed by the infusion of healthy stem cells to regenerate the bone marrow. It’s typically considered for aggressive or relapsed NHL cases.
For slow-growing (indolent) types of NHL, treatment might not start immediately. Doctors may recommend close monitoring until the disease shows signs of progression.
Before the Procedure
During the Procedure
After the Procedure
Non-Hodgkin’s Lymphoma (NHL) is a type of cancer that originates in the lymphatic system, primarily affecting lymphocytes, a type of white blood cell.
Common treatments include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and stem cell transplantation.
Many forms of NHL are treatable and even curable, especially when detected early. The prognosis depends on the subtype and stage of the disease.
Diagnosis typically involves blood tests, imaging scans (CT, PET), lymph node biopsy, and bone marrow biopsy.
Symptoms may include swollen lymph nodes, fever, night sweats, unexplained weight loss, and fatigue.
No, Non-Hodgkin’s Lymphoma is not contagious and cannot be spread from person to person.
Treatment duration varies depending on the type and stage, ranging from several weeks to months.
Yes, side effects can include fatigue, nausea, hair loss, infection risk, and low blood counts. Most are temporary and manageable.
The main difference is the presence of Reed-Sternberg cells in Hodgkin’s Lymphoma. NHL includes a broader range of lymphatic cancers.
Yes, NHL can relapse. In such cases, additional treatment options like stem cell transplants or clinical trials may be considered.
Yes, although more common in adults, NHL can also occur in children and adolescents.
No, it is typically reserved for aggressive or relapsed cases of Non-Hodgkin’s Lymphoma.
CAR T-cell therapy is a type of immunotherapy where a patient’s T-cells are genetically engineered to attack lymphoma cells.
A healthy diet, regular exercise, stress management, and avoiding infections can support treatment and recovery.
It can be detected early in some cases through awareness of symptoms and routine medical checkups.
The 5-year survival rate varies depending on the type and stage but ranges from 60% to 90% for many subtypes.
Yes, for slow-growing types of NHL, doctors may recommend monitoring the patient without immediate treatment.
Alternative therapies may support well-being but should never replace standard medical treatment. Always consult a specialist first.
A balanced diet rich in fruits, vegetables, lean proteins, and whole grains can help maintain strength and immune function during treatment.
Look for experienced oncologists or hematologists, board certification, hospital affiliations, patient reviews, and access to advanced treatments or clinical trials.
Oncology
Neurology
Gastroenterology
Pulmonology
Liver Transplant
Urology
Orthopedics
Cardiology
General Medicine
Gynecology
Pediatrics
Dermatology
040 6700 0000 
040 6700 0111
Doctor
Symptoms & Speciality